Wrong Policies Could Drive Investments Out of Japan amid China’s Rise, PhRMA Int’l Advocacy Chief Warns

Brian Toohey, Senior Vice President for International Advocacy, PhRMA For pharmaceutical companies, Japan has long been a priority market in Asia, but the “wrong type” of policies being rolled out in the country in recent years could change all that,...read more